A crystal ball is a clear path to Gross-to-Net visibility

GTN (Gross-to-Net) is all the buzz right now and for good reason. As the squeeze on margins get tighter and sales become more complex, managing your GTN and achieving an accurate forecast and clear view into a true net price of a product is difficult for Life Sciences manufacturers.

In the data science and analytics trend , we discuss how mathematical science gives you a crystal ball for visibility to your data. There’s a crystal ball to give you visibility in GTN as well if you’re willing to embrace where the industry is headed and work with a single source of truth to manage and accrue for discounts and other financial elements.

REVENUE
MANAGEMENT

The path
to the peak

What is revenue
management?

The umbrella
for all trends

Climbing the
peak has its perks

Pursuit of a
common goal

STRATEGIC
COLLABORATION

Partnerships
are pivotal

Shifting from M&A
to collaboration

CMO: A
rising star

The importance
of royalties

Emerging IP
agreements

Growing complexity
in royalty models

EMERGING
PRICING MODELS

In Life Sciences,
results really do matter

Bringing together
outcomes and value

Data is the
new currency

Data and detail
make the process

GROSS-TO-NET
ACCRUALS

A clear path to
GTN visibility

Why are GTN accruals
so important?

Manage GTN
accruals

Not a different result
with the same process

Integrating
contracts with GTN

DATA SCIENCE
& ANALYTICS

360°
visibility

What's hiding
in your data?

From reactive
to predictive

Relationships
matter

What gets measured
gets managed

Going from
HOW to WHY